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Abstract
Doxorubicin (DOX) is a widely prescribed antineoplastic and although the
precise mechanism(s) have yet to be identified, DOX-induced oxidative stress
to mitochondrial membranes is implicated in the pathogenic process. Previous
attempts to protect against DOX-induced cardiotoxicity with -tocopherol
(vitamin E) have met with limited success, possibly as a result of inadequate
delivery to relevant subcellular targets such as mitochondrial membranes.
The present investigation was designed to assess whether enrichment of car-
diac membranes with -ocopherol is sufficient to protect against DOX-induced
mitochondrial cardiotoxicity. Adult male Sprague-Dawley rats received seven
weekly subcutaneous injections of 2 mg/kg DOX and fed either standard diet
or diet supplemented with -tocopherol succinate. Treatment with a cumu-
lative dose of 14 mg/kg DOX caused mitochondrial cardiomyopathy as evi-
denced by histology, accumulation of oxidized cardiac proteins, and a signifi-
cant decrease in mitochondrial calcium loading capacity. Maintaining rats
on the -tocopherol supplemented diet resulted in a significant (two- to four-
fold) enrichment of cardiac mitochondrial membranes with -tocopherol and
diminished the content of oxidized cardiac proteins associated with DOX treat-
ment. However, dietary -tocopherol succinate failed to protect against mito-
chondrial dysfunction and cardiac histopathology. From this we conclude that
although dietary vitamin E supplementation enriches cardiac mitochondrial
membranes with -tocopherol, either (1) this tocopherol enrichment is not
sufficient to protect cardiac mitochondrial membranes from DOX toxicity or
(2) oxidative stress alone is not responsible for the persistent mitochondrial
cardiomyopathy caused by long-term DOX therapy.
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Introduction
Doxorubicin (DOX; Adriamycin®) is a highly potent anthracycline antineoplas-
tic widely prescribed for treating a variety of cancers including both solid tumors and
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